Veeva Accuses IQVIA of Scheme to Hinder Health Data Rivals

IQVIA Inc. was hit with a $200 million antitrust lawsuit July 18 claiming it’s protecting its stranglehold on the health data market by withholding data from companies that use competing reference software.

Drugmakers and other life sciences companies that want to use rival software still need IQVIA’s industry-leading data, without which the software is “essentially useless,” according to the complaint filed by software maker Veeva Systems Inc. IQVIA’s “longstanding practice” has been to make that data available to customers using platforms like Veeva’s under a “third-party access” agreement, the suit says.

But ever since Veeva rolled out data products that ...